151 related articles for article (PubMed ID: 10603666)
1. [Clinical characteristics and follow-up of patients attending a hospital hypertension clinic. 10-year experience].
Valero Capilla FA; Masana Marín L
An Med Interna; 1999 Oct; 16(10):498-503. PubMed ID: 10603666
[TBL] [Abstract][Full Text] [Related]
2. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
3. Improvement of blood pressure control in a hypertension clinic in Japan: a 15-year follow-up study.
Ohta Y; Matsumura K; Tsuchihashi T; Ohtsubo T; Arima H; Miwa Y; Goto K; Ohya Y; Fujii K; Uezono K; Abe I; Iida M
Clin Exp Hypertens; 2009 Oct; 31(7):553-9. PubMed ID: 19886853
[TBL] [Abstract][Full Text] [Related]
4. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
Román O; Cuevas G; Bunout D
Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
7. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
8. Treatment of 5413 hypertensive patients: a cross-sectional study.
Paulsen MS; Sondergaard J; Reuther L; Larsen PS; Munck AP; Larsen PV; Damsgaard J; Poulsen L; Hansen DG; Jacobsen IA; Larsen ML; Christensen HR; Christensen B; Andersen M
Fam Pract; 2011 Dec; 28(6):599-607. PubMed ID: 21596691
[TBL] [Abstract][Full Text] [Related]
9. The quality of arterial hypertension treatment in cardiology service in Kosovo--a single center study.
Bajraktari G; Sylejmani X; Thaçi K; Elezi S; Ndrepepa G
Anadolu Kardiyol Derg; 2009 Apr; 9(2):96-101. PubMed ID: 19357050
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive persistence and drug class.
Marentette MA; Gerth WC; Billings DK; Zarnke KB
Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
[TBL] [Abstract][Full Text] [Related]
11. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
[TBL] [Abstract][Full Text] [Related]
13. [Hypertension management in general practice in Iceland].
Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
[TBL] [Abstract][Full Text] [Related]
14. [Study on the compliance of antihypertensive drugs in patients with hypertension].
Guo H; He H; Jiang J
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Dec; 22(6):418-20. PubMed ID: 11851054
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
16. [Stress-associated hypertension in the work place: results of the STARLET project].
Lüders S; Hammersen F; Kulschewski A; Frerichs A; Frieg R; Hahnheiser D; Reich G; Schnieders M; Schrandt G; Schrader J
Dtsch Med Wochenschr; 2006 Nov; 131(46):2580-5. PubMed ID: 17096303
[TBL] [Abstract][Full Text] [Related]
17. Response of blood pressure to maximum exercise in hypertensive patients under different therapeutic programs.
de Queiroz Carreira MA; Ribeiro JC; Caldas JA; Tavares LR; Nani E
Arq Bras Cardiol; 2000 Oct; 75(4):281-8. PubMed ID: 11058925
[TBL] [Abstract][Full Text] [Related]
18. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
20. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
